Last Updated: November 12, 2026

Details for Patent: 11,337,989

« Back to Dashboard


Which drugs does patent 11,337,989 protect, and when does it expire?

Patent 11,337,989 protects PHEXX and is included in one NDA.

This patent has twenty-two patent family members in fourteen countries.

Summary for Patent: 11,337,989
Title:Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound
Abstract:The present disclosure relates to compositions and methods for inhibiting inflammation and reducing the risk of spreading sexually transmitted diseases using an alginic acid-based antimicrobial compound. Such compositions provide dual protection by (1) attacking and inactivating viruses and other microbes and (2) blocking the host response that viruses trigger to invade host cells. Such compositions can also be part of an acid buffering contraceptive.
Inventor(s):Wendell Guthrie, Gary S. Hahn
Assignee: Evofem Inc
Application Number:US15/106,755
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 11,337,989
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Drugs Protected by US Patent 11,337,989

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Evofem Inc PHEXX citric acid; lactic acid; potassium bitartrate GEL;VAGINAL 208352-001 May 22, 2020 RX Yes Yes 11,337,989 ⤷  Start Trial PREVENTION OF PREGNANCY ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 11,337,989

PCT Information
PCT FiledDecember 19, 2014PCT Application Number:PCT/US2014/071664
PCT Publication Date:June 25, 2015PCT Publication Number: WO2015/095793

International Family Members for US Patent 11,337,989

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014368971 ⤷  Start Trial
Australia 2020202835 ⤷  Start Trial
Brazil 112016014506 ⤷  Start Trial
China 106029078 ⤷  Start Trial
China 114452298 ⤷  Start Trial
Denmark 3082826 ⤷  Start Trial
European Patent Office 3082826 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.